节点文献

直肠肛管恶性黑色素瘤诊治体会

Diagnosis and treatment of anorectal malignant melanoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 朱玉萍冯海洋刘勇钱俊陈寅波李德川

【Author】 ZHU Yu-ping,FENG Hai-yang,LIU Yong,et al(Department of Colorectal Oncology,Zhejiang Cancer Hospital,Hangzhou 310022,China)

【机构】 浙江省肿瘤医院大肠外科

【摘要】 目的探讨直肠肛管恶性黑色素瘤的临床特点及生存分析。方法回顾性分析22例直肠肛管恶性黑色素瘤患者的临床资料和生存率。结果本组22例,占同期收治结直肠癌的0.3%(22/7300),首发症状为便血(77.3%),误诊率68.2%,首诊转移率63.6%;腹会阴联合切除术16例,局部切除术4例;辅助化疗9例,辅助免疫治疗6例;辅助放疗1例。22例患者1、3、5年生存率分别为54.5%、13.6%、9.1%。中位生存时间12月(95%CI:7.48-16.52)。结论直肠肛管恶性黑色素瘤少见,易误诊,易转移,预后差。外科治疗是目前无转移直肠肛管恶性黑色素瘤的首选治疗方法。

【Abstract】 Objective To review the diagnosis and treatment of anorectal malignant melanoma (ARMM). Methods Clinicopathological data,including clinical features,diagnosis,surgical modelities and prognosis of 22 patients with ARMM were analyzed retrospectively. Results Twenty-two ARMM cases were enrolled,which accounted for 0.3% of all admitted patients with colorectal cancer at the same period.The most common complaints were hematochezia(77.3%),and the misdiagnosis rate was 68.2%.The metastasis rate before diagnosis was 63.6%.Of 22 patients 16 underwent abdominoperineal resection,4 underwent extensive local excision,9 received adjuvant chemotherapy,6 received adjuvant immunotherapy and 1 received radiotherapy.The 1-,3-,and 5-year survival rates of the 22 patients were 54.5%,13.6% and 9.1%,respectively.The median survival time was 12 months (95% CI:7.48-16.52 months). Conclusions ARMM is a rare disease with poor prognosis,and surgery may be considered as the first choice for patients without distant metastasis.

  • 【文献出处】 实用肿瘤杂志 ,Journal of Practical Oncology , 编辑部邮箱 ,2009年04期
  • 【分类号】R735.3
  • 【被引频次】5
  • 【下载频次】163
节点文献中: 

本文链接的文献网络图示:

本文的引文网络